6-gingerol ameliorated doxorubicin-induced cardiotoxicity: Role of nuclear factor kappa B and protein glycation

El-Bakly, W.M. ; Louka, M.L. ; El-Halawany, A.M. ; Schaalan, M.F. 


Abstract


Doxorubicin is a widely used antitumour drug. Cardiotoxicity is considered a major limitation for its clinical use. The present study was designed to assess the possible antioxidant and antiapoptotic effects of 6-gingerol in attenuating doxorubicin-induced cardiac damage.


Other data

Issue Date 2012
Journal Cancer Chemotherapy and Pharmacology 
URI http://research.asu.edu.eg/123456789/254
DOI 6
833-41
http://www.scopus.com/inward/record.url?eid=2-s2.0-84871186031&partnerID=MN8TOARS
70
1432-0843
10.1007/s00280-012-1975-y


Recommend this item

CORE Recommender
24
Citations

10
Views


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.